• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Munters Group AB: Munters acquires animal health monitoring innovator Optifarm to strengthen Speria offering

Munters

Munters, a global leader in technologies that optimize climates, has acquired Optifarm, a UK-based provider of AI-driven livestock monitoring solutions. The acquisition strengthens the offering of operational intelligence solutions from Speria, the commercial brand for Munters FoodTech business area.

Optifarm's technology analyzes real-time animal behavior and environmental signals, such as water consumption patterns, to detect early signs of health deviations. These insights are translated into actionable insights that can be integrated into Speria's connected solutions of hardware, software and expert services.

"With Optifarm, we strengthen how animal health intelligence is embedded into mission-critical operations," says Pia Brantgärde Linder, President of FoodTech and GVP of Munters Group.  "Their expertise in translating real-time animal signals into decisions supports how we connect data, software with controllers to generate impact. This is a key step in building more predictive and autonomous operations over time."

Founded in 2014 and based in Chesterfield, UK, Optifarm has 14 employees and customers in 18 countries across Europe, the Middle East and Africa. The company has transitioned from a broiler farming service provider to focusing on AI-driven farm insights, and now operates in an early growth phase.